Gilead shows support for equitable healthcare for indigenous populations
Pharmaceutical companies are starting to acknowledge their responsibility to making access to medicine equitable to all, and Gilead Sciences are working towards their biggest commitment in this aspect, via a new initiative to enable health equity for Australian and Canadian Indigenous communities.
The initiative is focusing on the transmission of HIV and viral hepatitis in indigenous communities, working to support programmes and break down preconceptions and societal barriers that hinder the quality and access of care people in these communities receive.
To execute the plan, Gilead is working with organisations in the two countries – both indigenous-led – the Lowitja Institute in Australia and CAAN Communities, Alliances & Networks in Canada. Working together, the three organisations are creating a new, US$6 million grant programme, with the aim of spreading the funds out between the countries over the course of three years. The grant aims to provide much needed financial support to activities on the ground, led by organisations and initiatives dedicated to improving healthcare in indigenous communities.
There is a lot more dialogue in recent years surrounding the disparities in health care and subsequently health outcomes in indigenous populations, stemming from colonisation and the resulting oppression experienced by these communities, echoes of which still have a considerable effect today.
When studying the prevalence of these infectious diseases across Australia and Canada, there is a significantly higher rate in indigenous populations compared to in non-indigenous populations. The indigenous communities also encounter comparatively more barriers when looking to gain a diagnosis or access to the required treatment.
“We recognise that the Indigenous communities in both Australia and Canada have unique healthcare needs,” commented Alex Kalomparis, Senior Vice President, Public Affairs, Gilead Sciences. "Gilead's new funding program will help promote engagement in HIV and viral hepatitis care by supporting culturally appropriate solutions that address these needs, while enabling Indigenous people to continue advocating for the care of their communities."
Gilead strongly believe that more is needed than simply funding projects, and that by working closely with, listening to, and being guided by organisations headed by indigenous people, they can help to make a meaningful change in how indigenous communities are supported. By championing culturally important initiatives Gilead are hoping to see improvements in the discrepancy of care and health outcomes in indigenous populations were HIV and viral hepatitis infection prevalence is high.
The grant project is one aspect where Gilead is hoping to support more equitable access to healthcare globally, and combat the HIV epidemic.
Source: Gilead Sciences. Gilead Sciences Announces Its Largest Commitment to Health Equity for Australian and Canadian Indigenous Communities. [Date Accessed 27/07/2023]
Related News
-
News More to celebrate at the CPHI Milan Pharma Awards 2024
The CPHI Milan Pharma Awards, which are now open for nominations until 18 May 2024, celebrate the innovators making a difference. This year, two new categories have been added to further honour the contributions of a diverse range of pharma professiona... -
News Special Edition Women in Pharma: Women’s health and the pharmaceutical industry
International Women’s Day is an annual celebration of women around the world every March 8. March also marks Women’s History Month. This March, our Women in Pharma series takes a look at how women’s healthcare has developed, and the r... -
News Informa Markets International Women’s Day Panel Discussion
On March 7, 2024, the Informa Markets Amsterdam office hosted an International Women’s Day Breakfast and Panel Discussion to celebrate the women who drive the B2B events industry forward, including members of the CPHI team. -
News 5 African American Pharmaceutical Pioneers: Honouring Black History Month
In recognition of February as Black History Month in the United States, we cover the lives and works of five pioneering African American pharmaceutical professionals who have contributed significantly to the world of pharmaceuticals and drug devel... -
News Genome study discovers 275 million new variants across a diverse population
A new genome study undertaken in the US, accounting for a diverse range of people, has led to the discovery of nearly 300 million new genetic variants, which could inform markers of disease. -
News Special Edition Women in Pharma: International Day of Women and Girls in Science
In this monthly series, we bring insightful content, events, and communities dedicated to sharing best practices for DE&I strategies and showcasing underrepresented voices in the pharmaceutical community. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance